The MOA was signed by Chairman and Managing Director, NRDC Dr H.Purushotham and Director General, CCRAS Prof. Abhimanyu Kumar in the presence of Chief, NRDC, Shri A. Pradhan and other senior officers from CCRAS and NRDC.
Speaking on the occasion, CMD, NRDC Dr H.Purushotham, stated that NRDC has already transferred more than 10 technologies developed at CCRAS to more than 50 entrepreneurs/Industry which has helped both the organisations to earn a substantial amount of revenue . He was happy to inform that a number of Ayurvedic Medicines developed at CCRAS and commercialized by NRDC and are available to the public for the treatment of different diseases at an affordable price like Anti Malarial drug, Balrasayan, tonic for children, etc.
Commenting on the signing of the MOA, Prof. Abhimanyu Kumar, Director General, CCRAS appreciated the dedicated efforts made by NRDC for transferring a number of technologies developed at the different laboratories of CCRAS to a number of organisations in India.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
